Results
82 patients with a total of 235 APEs were treated with IV tobramycin
between January 2015 and December 2019. Of these, 31 were excluded due
to missing tobramycin serum concentration (n=28), for not being a
confirmed APE (n=1) or because treatment was initiated at another
hospital than the MUHC (n=2). In all, 51 patients with a total of 202
APEs were included.